-
JAMA Pediatrics
Comment & Response
February 20, 2023
Jennifer M. Nelson, MD, MPH; Katherine E. Fleming-Dutra, MD; Dana Meaney-Delman, MD, MPH
JAMA Pediatr. 2023; 177(4):438-439. 10.1001/jamapediatrics.2022.6024
-
JAMA
Original Investigation
May 13, 2022
Katherine E. Fleming-Dutra, MD; Amadea Britton, MD; Nong Shang, PhD; Gordana Derado, PhD; Ruth Link-Gelles, PhD; Emma K. Accorsi, PhD; Zachary R. Smith, MA; Joseph Miller, PhD; Jennifer R. Verani, MD; Stephanie J. Schrag, DPhil
free access
JAMA. 2022; 327(22):2210-2219. 10.1001/jama.2022.7493
This test-negative, case-control analysis evaluates the association of symptomatic infection with prior vaccination with BNT162b2 to estimate vaccine effectiveness among children and adolescents during Omicron variant predominance.
-
JAMA
Original Investigation
February 14, 2022
Amadea Britton, MD; Katherine E. Fleming-Dutra, MD; Nong Shang, PhD; Zachary R. Smith, MA; Tandin Dorji, MS; Gordana Derado, PhD; Emma K. Accorsi, PhD; Umed A. Ajani, MBBS, MPH; Joseph Miller, PhD; Stephanie J. Schrag, DPhil; Jennifer R. Verani, MD, MPH
free access
is active quiz
JAMA. 2022; 327(11):1032-1041. 10.1001/jama.2022.2068
This study estimates the associations between symptomatic SARS-CoV-2 infection and receipt of BNT162b2, mRNA-1273, and Ad26.COV2.S by day since vaccination before and during Delta variant predominance.
-
JAMA
Original Investigation
January 21, 2022
Emma K. Accorsi, PhD; Amadea Britton, MD; Katherine E. Fleming-Dutra, MD; Zachary R. Smith, MA; Nong Shang, PhD; Gordana Derado, PhD; Joseph Miller, PhD; Stephanie J. Schrag, DPhil; Jennifer R. Verani, MD, MPH
free access
is active quiz
JAMA. 2022; 327(7):639-651. 10.1001/jama.2022.0470
This case-control study uses data from the Centers for Disease Control and Prevention Increasing Community Access to Testing platform to estimate the association between receipt of 3 doses of Pfizer-BioNTech BNT162b2 or Moderna mRNA-1273 vaccine, compared with 2 doses or unvaccinated, and symptomatic SARS-CoV-2 infection, stratified by Omicron and Delta variant.
-
JAMA Pediatrics
Editorial
March 8, 2021
Sharon V. Tsay, MD; Adam L. Hersh, MD, PhD; Katherine E. Fleming-Dutra, MD
JAMA Pediatr. 2021; 175(5):462-463. 10.1001/jamapediatrics.2020.6743
-
JAMA Dermatology
Original Investigation
January 16, 2019
John S. Barbieri, MD, MBA; Ketaki Bhate, MBBS; Kathleen P. Hartnett, MPH, PhD; Katherine E. Fleming-Dutra, MD; David J. Margolis, MD, PhD
free access
has multimedia
JAMA Dermatol. 2019; 155(3):290-297. 10.1001/jamadermatol.2018.4944
This repeated cross-sectional analysis of antibiotic prescribing by dermatologists characterizes the use of antibiotics in dermatology, including changes over time, from 2008 to 2016.
-
JAMA Internal Medicine
Research Letter
September 1, 2018
Danielle L. Palms, MPH; Lauri A. Hicks, DO; Monina Bartoces, PhD; Adam L. Hersh, MD, PhD; Rachel Zetts, MPH; David Y. Hyun, MD; Katherine E. Fleming-Dutra, MD
free access
JAMA Intern Med. 2018; 178(9):1267-1269. 10.1001/jamainternmed.2018.1632
This cohort study compares antibiotic prescribing in 2014 among retail clinics, urgent care centers, emergency departments, and traditional medical offices in the United States.
-
JAMA Internal Medicine
Comment & Response
Less Is More
August 1, 2018
Laura M. King, MPH; Lauri A. Hicks, DO; Katherine E. Fleming-Dutra, MD
JAMA Intern Med. 2018; 178(8):1138-1139. 10.1001/jamainternmed.2018.3013
-
JAMA Internal Medicine
Research Letter
Less Is More
July 1, 2018
Laura M. King, MPH; Guillermo V. Sanchez, PA-C, MPH; Monina Bartoces, PhD; Lauri A. Hicks, DO; Katherine E. Fleming-Dutra, MD
free access
JAMA Intern Med. 2018; 178(7):992-994. 10.1001/jamainternmed.2018.0407
This study evaluates the duration of antibiotic therapy prescribed for US adults with sinusitis.
-
JAMA Internal Medicine
Research Letter
December 1, 2016
Adam L. Hersh, MD, PhD; Katherine E. Fleming-Dutra, MD; Daniel J. Shapiro, MD; David Y. Hyun, MD; Lauri A. Hicks, DO; for the Outpatient Antibiotic Use Target-Setting Workgroup
free access
JAMA Intern Med. 2016; 176(12):1870-1872. 10.1001/jamainternmed.2016.6625
This study measures the frequency with which first-line antibiotics are prescribed for otitis media, sinusitis, and pharyngitis.
-
JAMA
Comment & Response
May 17, 2016
Katherine E. Fleming-Dutra, MD; Cindy R. Friedman, MD; Lauri A. Hicks, DO
JAMA. 2016; 315(19):2121-2122. 10.1001/jama.2016.0918
-
JAMA
Original Investigation
May 3, 2016
Katherine E. Fleming-Dutra, MD; Adam L. Hersh, MD, PhD; Daniel J. Shapiro; Monina Bartoces, PhD; Eva A. Enns, PhD; Thomas M. File Jr, MD; Jonathan A. Finkelstein, MD, MPH; Jeffrey S. Gerber, MD, PhD; David Y. Hyun, MD; Jeffrey A. Linder, MD, MPH; Ruth Lynfield, MD; David J. Margolis, MD, PhD; Larissa S. May, MD, MSPH; Daniel Merenstein, MD; Joshua P. Metlay, MD, PhD; Jason G. Newland, MD, MEd; Jay F. Piccirillo, MD; Rebecca M. Roberts, MS; Guillermo V. Sanchez, MPH, PA-C; Katie J. Suda, PharmD, MS; Ann Thomas, MD, MPH; Teri Moser Woo, PhD; Rachel M. Zetts; Lauri A. Hicks, DO
free access
JAMA. 2016; 315(17):1864-1873. 10.1001/jama.2016.4151
This pharmacoepidemiology study estimates the rate of outpatient, oral antibiotic prescribing by age and diagnosis in the United States and the estimated portion of antibiotic use that may be inappropriate in adults and children.